Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of more than 500,000 QuickStrip™ units infused with Thrive Cannabis Inc.’s (“Thrive”) THC and CBD cannabis oils.
Currently sold in Ontario, Saskatchewan, Alberta, and British Columbia, RDT’s QuickStrips are sold under Thrive’s Being™ brand of THC and CBD 10mg oral strips.
“We continue to work collaboratively under agreement with a number of industry partners to bring QuickStrip™ cannabis products to market, which are quickly gaining in popularity within the recreational and medical markets as a result of their quick, convenient, precise, and discreet dosing experience,” said Mark Upsdell, CEO Rapid Dose Therapeutics. “We anticipate increased awareness of this novel delivery system will fuel the expansion of agreements with other leading cannabis brands.”
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
www.rapid-dose.com